Frédérique Bigonzi

2.9k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

Frédérique Bigonzi is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Frédérique Bigonzi has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 15 papers in Internal Medicine and 8 papers in Surgery. Recurrent topics in Frédérique Bigonzi's work include Acute Myocardial Infarction Research (15 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Frédérique Bigonzi is often cited by papers focused on Acute Myocardial Infarction Research (15 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Frédérique Bigonzi collaborates with scholars based in United States, France and United Kingdom. Frédérique Bigonzi's co-authors include Keith A.A. Fox, Enrique Gurfinkel, Gregg Fromell, Alexander G.G. Turpie, Anatoly Langer, Christine Demers, Robert M. Califf, Jerôme Premmereur, Shaun Goodman and Marc J. Cohen and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Frédérique Bigonzi

19 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 1.0k citations Marc J. Cohen, Christine Demers et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Frédérique Bigonzi

Since Specialization

Citations

This map shows the geographic impact of Frédérique Bigonzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Bigonzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Bigonzi more than expected).

Fields of papers citing papers by Frédérique Bigonzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédérique Bigonzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Bigonzi. The network helps show where Frédérique Bigonzi may publish in the future.

Co-authorship network of co-authors of Frédérique Bigonzi

This figure shows the co-authorship network connecting the top 25 collaborators of Frédérique Bigonzi. A scholar is included among the top collaborators of Frédérique Bigonzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérique Bigonzi. Frédérique Bigonzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study 2004 ·Catheterization and Cardiovascular Interventions ·Jack L. Martin, Edward T.A. Fry, (unknown), (unknown), (unknown), (unknown), Marie‐Laure Ozoux, (unknown), Frédérique Bigonzi	54
2	The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI) 2003 ·Journal of the American College of Cardiology ·Marc Cohen, Gian Franco Gensini, Frans Maritz, Enrique Gurfinkel, Kurt Huber, Ari Timerman, Maria Krzemińska‐Pakuła, Nicolas Danchin, Harvey D. White, José Santopinto, Frédérique Bigonzi, (unknown), Luc Vittori	48
3	Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non–ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention 2002 ·The American Journal of Cardiology ·Keith A.A. Fox, Elliott M. Antman, Marc Cohen, Frédérique Bigonzi	34
4	Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction 2002 ·Circulation ·Elliott M. Antman, Hans W. Louwerenburg, Hubert F. Baars, (unknown), Bas Hamer, Jean‐Pierre Bassand, Frédérique Bigonzi, (unknown), C. Michael Gibson, Hein Heidbüchel, Eugene Braunwald, Frans Van de Werf	156
5	Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study 2002 ·American Heart Journal ·Marc Cohen, Pierre Théroux, Steven Borzak, Martin J. Frey, Harvey D. White, W. Van Mieghem, Fred Senatore, (unknown), Robin Mukherjee, Kathy Harris, Frédérique Bigonzi	103
6	Enoxaparin with or without GPIIb/IIIa inhibition as reperfusion strategy in ST-segment elevation MI - results of the ENTIRE-TIMI 23 trial 2001 ·European Heart Journal ·EM Antman, Frédérique Bigonzi, C. Michael Gibson, Frans Van de Werf, (unknown), (unknown), (unknown), (unknown), Hein Heidbüchel, (unknown)	1
7	Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction 2001 ·The American Journal of Cardiology ·Scott D. Berkowitz, Sandra S. Stinnett, Marc Cohen, Gregg Fromell, Frédérique Bigonzi	25
8	Randomized trial of low molecular weight heparin (enoxaparin) vs. unfractionated heparin for unstable coronary artery disease: 1-year results of the ESSENCE study 2001 ·ACC Current Journal Review ·Shaun G. Goodman, Mauricio G. Cohen, Frédérique Bigonzi	0
9	Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin 2001 ·Circulation ·Allan M. Ross, Peter Molhoek, Conor F. Lundergan, M.L. Knudtson, (unknown), (unknown), (unknown), Frédérique Bigonzi, (unknown), (unknown), Karin S. Coyne	102
10	Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52. 2000 ·Journal of the American College of Cardiology ·Shaun G. Goodman, Marc Cohen, Frédérique Bigonzi, David Radley, Gregg Fromell, Enrique Gurfinkel, (unknown), Christine Demers, Alexander G.G. Turpie, Robert M. Califf, Keith A.A. Fox, Anatoly Langer	105
11	The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design 2000 ·Journal of Thrombosis and Thrombolysis ·Marc Cohen, Frans Maritz, Gian Franco Gensini, Nicolas Danchin, Ari Timerman, Kurt Huber, Enrique Gurfinkel, Harvey D. White, Keith A.A. Fox, Luc Vittori, (unknown), Frédérique Bigonzi	21
12	Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction 2000 ·The American Journal of Cardiology ·Marc Cohen, Elliott M. Antman, Enrique Gurfinkel, Alexander G.G. Turpie, (unknown), Frédérique Bigonzi, David Radley	9
13	Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial 1998 ·The American Journal of Cardiology ·Marc Cohen, Christine Demers, Enrique Gurfinkel, Alexander G.G. Turpie, Gregg Fromell, Shaun G. Goodman, Anatoly Langer, Robert M. Califf, Keith A.A. Fox, Jerôme Premmereur, Frédérique Bigonzi	68
14	One year follow-up of the ESSENCE trial (enoxaparin versus heparin in unstable angina and non-Q-wave myocardial infarction) 1998 ·Journal of the American College of Cardiology ·Mauricio G. Cohen, Frédérique Bigonzi, (unknown), (unknown), Gregg Fromell, Shaun Goodman	7
15	Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease 1998 ·Circulation ·Gilles Montalescot, Philippe François, Annick Ankri, Éric Vicaut, (unknown), (unknown), Didier Carrié, D Flammang, (unknown), A. Carayon, Claude Jardel, M. Chevrot, Jean Philippe Bastard, Frédérique Bigonzi, Daniel Thomas	209
16	A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease breakdown → 1997 ·New England Journal of Medicine ·Marc J. Cohen, Christine Demers, Enrique Gurfinkel, Alexander G.G. Turpie, Gregg Fromell, Shaun Goodman, Anatoly Langer, Robert M. Califf, Keith A.A. Fox, Jerôme Premmereur, Frédérique Bigonzi, (unknown), Beth Davison Weatherley	1004
17	Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre study 1993 ·International Journal of Cardiology ·Yves Juillière, Nicolas Danchin, Michel E. Bertrand, Jean Pierre Bassand, M Bory, Frédérique Bigonzi, R Grolleau, Jean M. Lablanche, Paul Barragan, (unknown), (unknown), François Cherrier	2
18	Non-invasive study of dual chamber pacing by pulsed Doppler. Prediction of the haemodynamic response by echocardiographic measurements 1989 ·European Heart Journal ·G Lascault, Frédérique Bigonzi, R Frank, Éric Abergel, (unknown), G Fontaine, Y Grosgogeat	9
19	[Use of molar lactate in intracavitary electrophysiological study of a ventricular tachycardia]. 1988 ·PubMed ·(unknown), Frédérique Bigonzi, (unknown), R Frank, G Fontaine, Y Grosgogeat	2
20	[Isolated pulmonary lymphoma in a patient with acquired immunodeficiency syndrome]. 1987 ·PubMed ·Frédérique Bigonzi, (unknown), P Fouret, (unknown), C Mayaud, G Akoun	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact